Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.4200
-0.0010 (-0.24%)
Apr 17, 2025, 4:00 PM EDT
Elite Pharmaceuticals Revenue
Elite Pharmaceuticals had revenue of $14.36M in the quarter ending December 31, 2024, a decrease of -7.56%. This brings the company's revenue in the last twelve months to $70.00M, up 47.93% year-over-year. In the fiscal year ending March 31, 2024, Elite Pharmaceuticals had annual revenue of $56.63M with 65.79% growth.
Revenue (ttm)
70.00M
Revenue Growth
+47.93%
P/S Ratio
6.43
Revenue / Employee
1.09M
Employees
64
Market Cap
449.74M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 56.63M | 22.47M | 65.79% |
Mar 31, 2023 | 34.16M | 1.89M | 5.87% |
Mar 31, 2022 | 32.26M | 6.88M | 27.11% |
Mar 31, 2021 | 25.38M | 7.39M | 41.05% |
Mar 31, 2020 | 17.99M | 10.43M | 137.76% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 16.04M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 210.49M |
American Oncology Network | 1.76B |
Longduoduo Company | 6.01M |
Elite Pharmaceuticals News
- 6 weeks ago - Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals Inc (ELTP) Q3 2025 Earnings Call Highlights: Record Revenue Growth Amid ... - GuruFocus
- 2 months ago - Q3 2025 Elite Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
- 2 months ago - Elite Pharmaceuticals Inc Reports Q3 2025 Revenue of $14.4 Million Amid Shipment Delays - GuruFocus
- 2 months ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025 - Newsfile Corp
- 4 months ago - Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R) - Newsfile Corp
- 4 months ago - Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets - Newsfile Corp